Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors
- PMID: 18948374
- DOI: 10.1677/ERC-08-0190
Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors
Abstract
The gastroprokinetic agent metoclopramide is known to stimulate catecholamine secretion from pheochromocytomas. The aim of the study was to investigate the mechanism of action of metoclopramide and expression of serotonin type 4 (5-HT(4)) receptors in pheochromocytoma tissues. Tissue explants, obtained from 18 pheochromocytomas including the tumor removed from a 46-year-old female patient who experienced life-threatening hypertension crisis after metoclopramide administration and 17 additional pheochromocytomas (9 benign and 8 malignant) were studied. Cultured pheochromocytoma cells derived from the patient who previously received metoclopramide were incubated with metoclopramide and various 5-HT(4) receptor ligands. In addition, total mRNAs were extracted from all the 18 tumors. Catecholamine- and granin-derived peptide concentrations were measured in pheochromocytoma cell incubation medium by HPLC and radioimmunological assays. In addition, expression of 5-HT(4) receptor mRNAs in the 18 pheochromocytomas was investigated by the use of reverse transcriptase-PCR.
Results: Metoclopramide and the 5-HT(4) receptor agonist cisapride were found to activate catecholamine- and granin-derived peptide secretions by cultured tumor cells. Metoclopramide- and cisapride-evoked catecholamine- and granin-derived peptide productions were inhibited by the 5-HT(4) receptor antagonist GR 113808. 5-HT(4) receptor mRNAs were detected in the patient's tumor and the series of 17 additional pheochromocytomas. This study shows that pheochromocytomas express functional 5-HT(4) receptors that are responsible for the stimulatory action of metoclopramide on catecholamine- and granin-derived peptide secretion. All 5-HT(4) receptor agonists must therefore be contraindicated in patients with proven or suspected pheochromocytoma.
Similar articles
-
Cardiovascular effects of metoclopramide and domperidone on human 5-HT4-serotonin-receptors in transgenic mice and in human atrial preparations.Eur J Pharmacol. 2021 Jun 15;901:174074. doi: 10.1016/j.ejphar.2021.174074. Epub 2021 Mar 31. Eur J Pharmacol. 2021. PMID: 33811834
-
Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies.J Clin Endocrinol Metab. 2002 Mar;87(3):1211-6. doi: 10.1210/jcem.87.3.8327. J Clin Endocrinol Metab. 2002. PMID: 11889190 Clinical Trial.
-
Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival.Endocr Relat Cancer. 2010 Jun 25;17(3):637-51. doi: 10.1677/ERC-10-0109. Print 2010 Sep. Endocr Relat Cancer. 2010. PMID: 20483910
-
Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.Regul Pept. 2010 Nov 30;165(1):21-9. doi: 10.1016/j.regpep.2010.06.003. Epub 2010 Jun 18. Regul Pept. 2010. PMID: 20600356 Review.
-
Translating 5-HT receptor pharmacology.Neurogastroenterol Motil. 2009 Dec;21(12):1235-8. doi: 10.1111/j.1365-2982.2009.01425.x. Neurogastroenterol Motil. 2009. PMID: 19906028 Review.
Cited by
-
Illicit Upregulation of Serotonin Signaling Pathway in Adrenals of Patients With High Plasma or Intra-Adrenal ACTH Levels.J Clin Endocrinol Metab. 2019 Nov 1;104(11):4967-4980. doi: 10.1210/jc.2019-00425. J Clin Endocrinol Metab. 2019. PMID: 31074783 Free PMC article.
-
Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.J Am Coll Cardiol. 2020 Jul 28;76(4):451-464. doi: 10.1016/j.jacc.2020.04.080. J Am Coll Cardiol. 2020. PMID: 32703516 Free PMC article. Review.
-
Characterization of the EM66 Biomarker in the Pituitary and Plasma of Healthy Subjects With Different Gonadotroph Status and Patients With Gonadotroph Tumor.Front Endocrinol (Lausanne). 2019 Feb 22;10:102. doi: 10.3389/fendo.2019.00102. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30853937 Free PMC article.
-
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach.Curr Oncol Rep. 2022 Jan;24(1):89-98. doi: 10.1007/s11912-022-01197-0. Epub 2022 Jan 21. Curr Oncol Rep. 2022. PMID: 35061191 Review.
-
Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.PLoS One. 2014 Feb 11;9(2):e88698. doi: 10.1371/journal.pone.0088698. eCollection 2014. PLoS One. 2014. PMID: 24523932 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical